Development of a novel trans-lentiviral vector that affords predictable safety

Molecular Therapy

Volumn 2, Issue 1, 2000, Pages 47-55

  Wu, Xiaoyun ^a   Wakefield, John K ^c   Liu, Hongmei ^a   Xiao, Hongling ^a   Kralovics, Robert ^a   Prchal, Josef T ^a   Kappes, John C ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c Tranzyme Inc   (United States)

Author keywords

Gag pro; Gene therapy; HIV; Lentiviral vector; Vpr RT IN

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

CD34 ANTIGEN; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN; VIRUS PROTEIN; VPR PROTEIN;

ARTICLE; BIOLOGICAL MODEL; BONE MARROW CELL; CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; VIROLOGY;

ANTIGENS, CD34; BASE SEQUENCE; BONE MARROW CELLS; CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, VPR; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HIV-1; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; MACROPHAGES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PLASMIDS; RECOMBINATION, GENETIC; VIRAL PROTEINS;

EID: 0034218268     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0095     Document Type: Article

References (29)

1. Amado, R. G., and Chen, I. S. Y. (1999). Lentiviral vectors - The promise of gene therapy within reach? Science 285: 674-676.
2. An, D. S., et al. (2000). Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34+ cells. J. Virol. 74: 1286-1295.
3. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J.-K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl. Acad. Sci. USA 90: 8033-8037.
4. Clavel, F., and Charneau, P. (1994). Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68: 1179-1185.
5. Dull, T., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
6. Endres, M. J., et al. (1997). Targeting of HIV-and SIV-infected cells by CD4-chemokine receptor pseudotypes. Science 278: 1462-1464.
7. Ghosh, S. K., et al. (1993). A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology 194: 858-864.
8. Huang, C. C., Hay, N., and Bishop, J. M. (1986). The role of RNA molecules in transduction of the proto-oncogene c-fps. Cell 44: 935-940.
9. Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., and Verma, I. M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17: 314-317.
10. Kafri, T., Van Praag, H., Ouyang, L., Gage, F., and Verma, I. M. (1999). A packaging cell line for lentivirus vectors. J. Virol. 73: 576-584.
11. Kim, V. N., Mitrophanous, K., Kingsman, S. M., and Kingsman, A. J. (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72: 811-816.
12. Liu, H., Wu, X., Xiao, H., Conway, J. A., and Kappes, J. C. (1997). Incorporation of functional human immunodeficiency virus Type 1 integrase into virions independent of the Gag/Pol precursor protein. J. Virol. 71: 7701-7710.
13. Luhovy, M., McCune, S., Ding, J. Y., Prchal, J. F., Townes, T. M., and Prchal, J. T. (1996). Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients. Biol. Blood Marrow Transplant. 2: 24-30.
14. Mebatsion, T., Finke, S., Weiland, F., and Conzelmann, K.-K. (1997). A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-ex pressing cells. Cell 90: 841-847.
15. Miller, M. D., Farnet, C. M., and Bushman, F. D. (1997). Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition. J. Virol. 71: 5382-5390.
16. Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., and Torbett, B. E. (1999). Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283: 682-686.
17. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. A. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93: 11382-11388.
18. Naldini, L., et al. (1996). In vivo gene delivery and stable gene transduction of non-dividing cells by a lentivirus vector. Science 272: 263-267.
19. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93: 11400-11406.
20. Park, F., Ohashi, K., Chiu, W., Naldini, L., and Kay, M. (2000). Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24: 49-52.
21. Raines, M. A., Maihle, N. J., Mascovici, C., Crittenden, L., and Kung, H.-J. (1988). Mechanism of c-erbB transduction: Newly released transducing viruses retain poly(A) tracts of erbB transcripts and encode C-terminally intact erbB proteins. J. Virol. 62: 2437-2443.
22. Schnell, M. J., Johnson, J. E., Buonocore, L., and Rose, J. K. (1997). Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90: 849-857.
23. Swanstrom, R., and Wills, J. W. (1997). Synthesis, assembly, and processing of viral proteins. In Retroviruses (J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds.), pp. 263-334. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Wu, X., et al. (1999). Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J. Virol. 73: 2126-2135.
25. Wu, X., et al. (1997). Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J. 16: 5113-5122.
26. Wu, X., Liu, H., Xiao, H., Conway, J. A., and Kappes, J. C. (1996). Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J. Virol. 70: 3378-3384.
27. Wu, X., et al. (1995). Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J. Virol. 69: 3389-3398.
28. Zennou, V., et al. (2000). HIV-1 genome nuclear flap import is mediated by a central DNA flap. Cell 101: 173-185.
29. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15: 871-875.